Amos Ron

Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel.

Atlantium Technologies Ltd. develops and provides water treatment solutions. The firm provides water disinfection solutions that help water dependent industries such as food and beverage, dairy, and aquaculture as well as municipalities build, expand and operate water-intensive processes. Its hydro-optic disinfection solutions deliver unprecedented microbial inactivation, taking cost-effective, and environmentally-friendly water disinfection to levels never before attained. The company was founded by Benjamin Kahn in 2003 and is headquartered in Beit Shemesh, Israel.

Part of Merck KGaA, Interpharm Laboratories Ltd. is an Israeli company that develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases. The company is based in Rehovot, Israel. The company was founded by Israel Makov.